Combination Therapy of Navitoclax with Chemotherapeutic Agents in Solid Tumors and Blood Cancer: A Review of Current EvidenceNur Syahidah Nor Hisam, Nur Najmi Mohamad Anuar, Mohd Faizal Ahmad et al.|Pharmaceutics|2021Cited by 41